Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp KHRNF


Primary Symbol: V.KHRN.H Alternate Symbol(s):  V.KHRN.W.H | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > IS KHRN the real deal?
View:
Post by Bu11ish0NG0ld on Jan 13, 2021 10:59am

IS KHRN the real deal?

I am an investor in KHRN but its movement lately worries me. I have APHA, NDVA & BHNG all of them now moving up in price but KHRN has been dead money for me so far. I am holding onto it for now, but if the other marijuana stocks I own keep rising in stock price and KHRN doesn't in the next few months then KHRN could be nothing more than an illusion to futire wealth. Just my take. GLTA!
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities